$75.56 -0.13 (-0.17%) Bristol-Myers Squibb Co - New York Stock Exchange, Inc.

Jul. 25, 2016 | 03:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 75.56
Trade Time: Jul 25 03:00 PM Eastern Daylight Time
Change: -0.13 (-0.17%)
Prev Close: 75.68
Open: 75.70
Bid: 75.55
Ask: 75.56
  1. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  2. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 13:57PM EST
  3. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus | Jul. 11, 2016 | 05:31AM EST
  4. Bristol-Myers Looks To A Promising Future

    Benzinga | Feb. 17, 2016 | 08:17AM EST
  5. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More

    Benzinga | Feb. 14, 2016 | 14:09PM EST
  6. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  7. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  8. Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance

    Benzinga | Jan. 28, 2016 | 07:54AM EST
  9. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  10. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga | Jan. 25, 2016 | 11:43AM EST
  11. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga | Jan. 25, 2016 | 10:25AM EST
  12. Benzinga's Top Downgrades

    Benzinga | Jan. 25, 2016 | 09:30AM EST
  13. Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status1

    Benzinga | Jan. 24, 2016 | 06:55AM EST
  14. Benzinga's Top Upgrades

    Benzinga | Jan. 22, 2016 | 08:50AM EST
  15. Fast Money Traders Share Their Biotech Picks

    Benzinga | Jan. 12, 2016 | 07:14AM EST
Trading Center